Literature DB >> 2418447

Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia.

C Okuda, A Saito, M Miyazaki, K Kuriyama.   

Abstract

The alteration of monoamines and their metabolites in the brain in response to hypothermia was studied using rats subjected to a cold and immobilization stress. The experiments were designed to compare the responses in the "hypothermal" rats with those in the "normothermal" ones which received the same stress except for the change in body temperature. It has been found that the contents of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) in various cerebral regions were significantly decreased during hypothermia. These decreases were readily reversed by the rewarming of animals. Moreover, the increase in the content of 5-hydroxyindole-3-acetic acid (5-HIAA), the metabolite of 5-HT, was also detected in some cerebral regions where the decrease of 5-HT was observed. Although the dopamine (DA) contents in all cerebral regions examined were found to be unaltered, its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and/or homovanillic acid (HVA) contents in most regions in the brain showed a significant elevation during and/or after the occurrence of hypothermia. These results suggest that the metabolic turnovers of 5-HT and DA in various cerebral regions may be accelerated during hypothermia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418447     DOI: 10.1016/0091-3057(86)90048-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Changes in brain monoamine metabolism in rats with acute ischemic hepatic failure under artificial cardiopulmonary management.

Authors:  N Murakami; K Saito; T Kato; T Nakamura; U Moriwaki; Y Muto
Journal:  Gastroenterol Jpn       Date:  1992-04

2.  Hypothermia reduces calcium entry via the N-methyl-D-aspartate and ryanodine receptors in cultured hippocampal neurons.

Authors:  Kristin F Phillips; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2012-10-17       Impact factor: 4.432

3.  Therapeutic benefits of mild hypothermia in patients successfully resuscitated from cardiac arrest: A meta-analysis.

Authors:  Xiao-Ping Wang; Qing-Ming Lin; Shen Zhao; Shi-Rong Lin; Feng Chen
Journal:  World J Emerg Med       Date:  2013

Review 4.  Use of hypothermia in the intensive care unit.

Authors:  Jesse J Corry
Journal:  World J Crit Care Med       Date:  2012-08-04

Review 5.  Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation.

Authors:  Jasmin Arrich; Michael Holzer; Christof Havel; Marcus Müllner; Harald Herkner
Journal:  Cochrane Database Syst Rev       Date:  2016-02-15

6.  Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.

Authors:  M T Bardo; S L Bowling; R C Pierce
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 7.  Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury.

Authors:  H Ma; B Sinha; R S Pandya; N Lin; A J Popp; J Li; J Yao; X Wang
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

8.  DNA microarray analysis of the mouse adrenal gland for the detection of hypothermia biomarkers: potential usefulness for forensic investigation.

Authors:  Masataka Takamiya; Kiyoshi Saigusa; Koji Dewa
Journal:  Ther Hypothermia Temp Manag       Date:  2013-06       Impact factor: 1.286

9.  Neuronal apoptosis can be prevented by the combined therapy with melatonin and hypothermia in a neonatal rat model of hypoxic-ischemic encephalopathy.

Authors:  Alina Mihaela Toader; Oana Hoteiuc; Cristina Bidian; Dan-Daniel Oltean; Flaviu Tabaran; Ovidiu Grad; Simona Clichici; Daniela Rodica Mitrea
Journal:  Med Pharm Rep       Date:  2021-04-29

10.  Therapeutic hypothermia: critical review of the molecular mechanisms of action.

Authors:  Fernando Pavel González-Ibarra; Joseph Varon; Elmer G López-Meza
Journal:  Front Neurol       Date:  2011-02-03       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.